Fund moves

Hims & Hers Health (HIMS): Carnegie Investment Counsel reduced its stake -211K shares

Carnegie Investment Counsel reduced its stake in Hims & Hers Health, per its Q4 2025 13F.

93K
Shares reported · -211K vs prior quarter
0.06%
Disclosed portfolio weight
$3.03M
Reported value
Holdings as of
Dec 31, 2025
Filed
Jan 23, 2026

What stands out in this filing

  • 303,909 shares in Q3 2025, 93,334 now (−69.3% in share count).
  • Reported at $3.03M, 0.06% of the portfolio value in this 13F filing.
  • 8 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 24, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
  2. Dec 9, 2025InsiderDirector sold ~$98K of HIMS shares in the open market
  3. Dec 17, 2025Insider · 4 peopleInsiders: 4 sales (~$1.4M)
  4. Dec 22, 2025InsiderCFO sold ~$825K of HIMS shares in the open market
  5. Jan 5, 2026InsiderCFO sold ~$306K of HIMS shares in the open market
  6. Jan 20, 2026InsiderCFO sold ~$275K of HIMS shares in the open market

What came next

  1. Feb 3, 2026InsiderCFO sold ~$139K of HIMS shares in the open market
  2. Feb 19, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  3. Feb 23, 2026Company filing · Form 8-K · ResultsReported its results
  4. Feb 27, 2026InsiderOfficer sold ~$71K of HIMS shares in the open market
  5. Mar 17, 2026Insider · 3 peopleInsiders: 3 sales (~$2.7M)
  6. Mar 20, 2026InsiderCFO sold ~$219K of HIMS shares in the open market
  7. Apr 6, 2026InsiderCFO sold ~$79K of HIMS shares in the open market
  8. Apr 16, 2026InsiderCFO sold ~$956K of HIMS shares in the open market
  9. Apr 17, 2026InsiderCFO sold ~$501K of HIMS shares in the open market
  10. Apr 20, 2026Insider · 2 peopleInsiders: 2 sales (~$873K)
  11. May 11, 2026Company filing · Form 8-K · ResultsReported its results
  12. May 18, 2026InsiderCFO sold ~$188K of HIMS shares in the open market
  13. May 21, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

How this filing works

Explore the data

Common questions

What does this filing report about Hims & Hers Health (HIMS) stock?

Carnegie Investment Counsel reduced its stake in Hims & Hers Health, per its Q4 2025 13F. Now 93K shares, $3.03M reported value, 0.06% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Jan 23, 2026.

What stands out in this filing?

303,909 shares in Q3 2025, 93,334 now (−69.3% in share count). Reported at $3.03M, 0.06% of the portfolio value in this 13F filing. 8 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data